PT1112251E - Derivados de azetidina sua preparacao e medicamentos que os contem - Google Patents

Derivados de azetidina sua preparacao e medicamentos que os contem

Info

Publication number: PT1112251E
Authority: PT; Portugal
Prior art keywords: medicines; contain; preparation; azetidine derivatives; azetidine
Prior art date: 1998-09-11

Application number

PT99941728T

Other languages

English (en)

Inventor

Serge Mignani

Daniel Achard

Serge Grisoni

Augustin Hittinger

Marc Capet

Herve Bouchard

Jean Bouquerel

Jean-Luc Malleron

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-11

Filing date

1999-09-09

Publication date

2003-09-30

1999-09-09 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2003-09-30 Publication of PT1112251E publication Critical patent/PT1112251E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Cardiology (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
Addiction (AREA)
Rheumatology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Obesity (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)

PT99941728T 1998-09-11 1999-09-09 Derivados de azetidina sua preparacao e medicamentos que os contem PT1112251E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9811342A FR2783246B1 (fr)	1998-09-11	1998-09-11	Derives d'azetidine, leur preparation et les medicaments les contenant
US11992999P	1999-02-12	1999-02-12

Publications (1)

Publication Number	Publication Date
PT1112251E true PT1112251E (pt)	2003-09-30

Family

ID=9530327

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT99941728T PT1112251E (pt)	1998-09-11	1999-09-09	Derivados de azetidina sua preparacao e medicamentos que os contem

Country Status (26)

Country	Link
EP (1)	EP1112251B1 (pt)
JP (1)	JP4767413B2 (pt)
CN (1)	CN1149191C (pt)
AR (1)	AR021483A1 (pt)
AT (1)	ATE239703T1 (pt)
AU (1)	AU772025B2 (pt)
BR (1)	BR9913592A (pt)
CA (1)	CA2342739C (pt)
CO (1)	CO5150230A1 (pt)
CZ (1)	CZ301446B6 (pt)
DE (1)	DE69907698T2 (pt)
DK (1)	DK1112251T3 (pt)
DZ (1)	DZ2887A1 (pt)
ES (1)	ES2197666T3 (pt)
FR (1)	FR2783246B1 (pt)
HU (1)	HUP0103341A3 (pt)
MA (1)	MA26685A1 (pt)
MY (1)	MY119150A (pt)
PL (1)	PL198526B1 (pt)
PT (1)	PT1112251E (pt)
RU (1)	RU2230739C2 (pt)
TN (1)	TNSN99168A1 (pt)
TR (1)	TR200100693T2 (pt)
TW (1)	TW530046B (pt)
WO (1)	WO2000015609A1 (pt)
ZA (1)	ZA200102003B (pt)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2799124B1 (fr) *	1999-10-01	2004-08-13	Sanofi Synthelabo	Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments
US6956033B2 (en)	2000-08-01	2005-10-18	Ono Pharmaceutical Co., Ltd.	3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
FR2814678B1 (fr) *	2000-10-04	2002-12-20	Aventis Pharma Sa	Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
FR2829028B1 (fr) *	2001-08-29	2004-12-17	Aventis Pharma Sa	Association d'un antagoniste du recepteur cb1 et d'un produit qui active la neurotransmission dopaminergique dans le cerveau, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de
US7109216B2 (en)	2001-09-21	2006-09-19	Solvay Pharmaceuticals B.V.	1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
FR2833842B1 (fr) *	2001-12-21	2004-02-13	Aventis Pharma Sa	Compositions pharmaceutiques a base de derives d'azetidine
CA2478338A1 (en)	2002-03-08	2003-09-18	Signal Pharmaceuticals, Inc.	Combination therapy for treating, preventing or managing proliferative disorders and cancers
US6825209B2 (en)	2002-04-15	2004-11-30	Research Triangle Institute	Compounds having unique CB1 receptor binding selectivity and methods for their production and use
ATE389646T1 (de)	2002-07-29	2008-04-15	Hoffmann La Roche	Neue benzodioxole
US7129239B2 (en)	2002-10-28	2006-10-31	Pfizer Inc.	Purine compounds and uses thereof
US7247628B2 (en)	2002-12-12	2007-07-24	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
RU2330035C2 (ru)	2003-01-02	2008-07-27	Ф.Хоффманн-Ля Рош Аг	Пирролилтиазолы и фармацевтическая композиция, обладающая свойством модулятора рецептора св1
TW200413328A (en)	2003-01-02	2004-08-01	Hoffmann La Roche	Novel CB 1 receptor inverse agonists
US7329658B2 (en)	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
US7268133B2 (en)	2003-04-23	2007-09-11	Pfizer, Inc. Patent Department	Cannabinoid receptor ligands and uses thereof
US7141669B2 (en)	2003-04-23	2006-11-28	Pfizer Inc.	Cannabiniod receptor ligands and uses thereof
US7145012B2 (en)	2003-04-23	2006-12-05	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
FR2854633B1 (fr) *	2003-05-07	2005-06-24	Sanofi Synthelabo	Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique
US7232823B2 (en)	2003-06-09	2007-06-19	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
RU2006100298A (ru)	2003-06-11	2006-05-10	Мерк энд Ко., Инк. (US)	Замещенные производные 3-алкил-и 3-алкенилазетидинов
DE602004012858T2 (de)	2003-06-20	2009-05-14	F. Hoffmann-La Roche Ag	2-aminobenzothiazole als cb1 rezeptor inverse agonisten
AU2004299198A1 (en)	2003-12-08	2005-06-30	F. Hoffmann-La Roche Ag	Novel thiazole derivates
ATE478856T1 (de)	2004-01-28	2010-09-15	Hoffmann La Roche	Spirobenzodioxole und deren verwendung als cb1- antagonisten
ATE432275T1 (de)	2004-05-10	2009-06-15	Hoffmann La Roche	Pyrrol- bzw. imidazolamide zur behandlung von obesitas
ES2309812T3 (es)	2004-10-27	2008-12-16	F. Hoffmann-La Roche Ag	Nuevos derivados de indol o benzimidazol.
WO2006050842A1 (en)	2004-11-09	2006-05-18	F. Hoffmann-La Roche Ag	Dibenzosuberone derivatives
BRPI0609685A2 (pt)	2005-04-06	2010-04-20	Hoffmann La Roche	compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para tratamento e/ou profilaxia de enfermidades que estão associados com a modulação de receptores de cb1, e utilização dos mesmos
JP4943826B2 (ja) *	2005-11-25	2012-05-30	田辺三菱製薬株式会社	医薬組成物
US7906652B2 (en)	2005-11-28	2011-03-15	Merck Sharp & Dohme Corp.	Heterocycle-substituted 3-alkyl azetidine derivatives
US7629346B2 (en)	2006-06-19	2009-12-08	Hoffmann-La Roche Inc.	Pyrazinecarboxamide derivatives as CB1 antagonists
MX2009001043A (es)	2006-08-08	2009-02-06	Sanofi Aventis	Imidazolidina-2,4-dionas sustituidas con arilaminoarilalquilo, procedimiento para preparalas, medicamentos que comprenden estos compuestos y su uso.
BRPI0716134A2 (pt)	2006-09-07	2013-09-17	Nycomed Gmbh	tratamento de combinaÇço para diabetes mellitus
US7781593B2 (en)	2006-09-14	2010-08-24	Hoffmann-La Roche Inc.	5-phenyl-nicotinamide derivatives
JP5508258B2 (ja)	2007-06-04	2014-05-28	ベングリオンユニバーシティオブザネガフリサーチアンドディベロップメントオーソリティ	トリアリール化合物および前記化合物を含む組成物
EP2025674A1 (de)	2007-08-15	2009-02-18	sanofi-aventis	Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
UY31968A (es)	2008-07-09	2010-01-29	Sanofi Aventis	Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
CA2771278A1 (en)	2009-08-26	2011-03-03	Sanofi	Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
US8933024B2 (en)	2010-06-18	2015-01-13	Sanofi	Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
WO2012120054A1 (de)	2011-03-08	2012-09-13	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120051A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8809324B2 (en)	2011-03-08	2014-08-19	Sanofi	Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
US8871758B2 (en)	2011-03-08	2014-10-28	Sanofi	Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2012120058A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120057A1 (de)	2011-03-08	2012-09-13	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2766349B1 (de)	2011-03-08	2016-06-01	Sanofi	Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8828995B2 (en)	2011-03-08	2014-09-09	Sanofi	Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120055A1 (de)	2011-03-08	2012-09-13	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
CA2838765C (en) *	2011-06-10	2019-05-07	Chiesi Farmaceutici S.P.A.	Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
EP2567959B1 (en)	2011-09-12	2014-04-16	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2015068156A1 (en)	2013-11-05	2015-05-14	Ben-Gurion University Of The Negev Research And Development Authority	Compounds for the treatment of diabetes and disease complications arising from same
CN115124447A (zh) *	2022-08-29	2022-09-30	山东诚创蓝海医药科技有限公司	一种3-氮杂环丁酮盐酸盐的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4133881A (en) *	1977-04-27	1979-01-09	A. H. Robins Company, Incorporated	Azetidinyl acetonitrile and acetamide antiarrhythmia compositions and methods
US4242261A (en) *	1979-07-19	1980-12-30	A. H. Robins Company, Inc.	Production of methylene-cycloamines
US4260606A (en) *	1979-07-19	1981-04-07	A. H. Robins Company, Inc.	3-Methyleneazetidine derivatives
US5151418A (en) *	1985-02-28	1992-09-29	A. H. Robins Company, Incorporated	Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides
US5183902A (en) *	1985-02-28	1993-02-02	A. H. Robins Company, Incorporated	Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides

1998
- 1998-09-11 FR FR9811342A patent/FR2783246B1/fr not_active Expired - Fee Related
1999
- 1999-09-01 TW TW088115056A patent/TW530046B/zh not_active IP Right Cessation
- 1999-09-07 MY MYPI99003867A patent/MY119150A/en unknown
- 1999-09-08 TN TNTNSN99168A patent/TNSN99168A1/fr unknown
- 1999-09-08 DZ DZ990187A patent/DZ2887A1/xx active
- 1999-09-08 MA MA25758A patent/MA26685A1/fr unknown
- 1999-09-09 EP EP99941728A patent/EP1112251B1/fr not_active Expired - Lifetime
- 1999-09-09 CA CA002342739A patent/CA2342739C/fr not_active Expired - Fee Related
- 1999-09-09 DK DK99941728T patent/DK1112251T3/da active
- 1999-09-09 AU AU55232/99A patent/AU772025B2/en not_active Ceased
- 1999-09-09 RU RU2001110080/04A patent/RU2230739C2/ru not_active IP Right Cessation
- 1999-09-09 BR BR9913592-2A patent/BR9913592A/pt not_active Application Discontinuation
- 1999-09-09 HU HU0103341A patent/HUP0103341A3/hu unknown
- 1999-09-09 PT PT99941728T patent/PT1112251E/pt unknown
- 1999-09-09 CN CNB99810762XA patent/CN1149191C/zh not_active Expired - Fee Related
- 1999-09-09 TR TR2001/00693T patent/TR200100693T2/xx unknown
- 1999-09-09 AT AT99941728T patent/ATE239703T1/de active
- 1999-09-09 WO PCT/FR1999/002147 patent/WO2000015609A1/fr not_active Application Discontinuation
- 1999-09-09 PL PL346530A patent/PL198526B1/pl not_active IP Right Cessation
- 1999-09-09 JP JP2000570149A patent/JP4767413B2/ja not_active Expired - Fee Related
- 1999-09-09 ES ES99941728T patent/ES2197666T3/es not_active Expired - Lifetime
- 1999-09-09 CZ CZ20010883A patent/CZ301446B6/cs not_active IP Right Cessation
- 1999-09-09 DE DE69907698T patent/DE69907698T2/de not_active Expired - Lifetime
- 1999-09-10 CO CO99057627A patent/CO5150230A1/es unknown
- 1999-09-10 AR ARP990104563A patent/AR021483A1/es active IP Right Grant
2001
- 2001-03-08 ZA ZA200102003A patent/ZA200102003B/en unknown

Also Published As

Publication number	Publication date
CZ301446B6 (cs)	2010-03-03
FR2783246B1 (fr)	2000-11-17
WO2000015609A1 (fr)	2000-03-23
BR9913592A (pt)	2001-06-12
MY119150A (en)	2005-04-30
CA2342739A1 (fr)	2000-03-23
TR200100693T2 (tr)	2001-07-23
JP4767413B2 (ja)	2011-09-07
HUP0103341A3 (en)	2002-10-28
TW530046B (en)	2003-05-01
DE69907698D1 (de)	2003-06-12
CN1149191C (zh)	2004-05-12
ATE239703T1 (de)	2003-05-15
AU772025B2 (en)	2004-04-08
DE69907698T2 (de)	2004-03-25
CN1316991A (zh)	2001-10-10
AU5523299A (en)	2000-04-03
CO5150230A1 (es)	2002-04-29
TNSN99168A1 (fr)	2005-11-10
EP1112251A1 (fr)	2001-07-04
DK1112251T3 (da)	2003-09-01
EP1112251B1 (fr)	2003-05-07
HUP0103341A2 (hu)	2002-02-28
CZ2001883A3 (en)	2001-06-13
ZA200102003B (en)	2002-08-28
MA26685A1 (fr)	2004-12-20
AR021483A1 (es)	2002-07-24
RU2230739C2 (ru)	2004-06-20
ES2197666T3 (es)	2004-01-01
JP2002525267A (ja)	2002-08-13
CA2342739C (fr)	2009-09-08
DZ2887A1 (fr)	2003-12-15
PL198526B1 (pl)	2008-06-30
PL346530A1 (en)	2002-02-11
FR2783246A1 (fr)	2000-03-17

Publication	Publication Date	Title
PT1112251E (pt)	2003-09-30	Derivados de azetidina sua preparacao e medicamentos que os contem
PT876362E (pt)	2004-02-27	Novos taxoides sua preparacao e composicoes farmaceuticas que os contem
PT835246E (pt)	2002-04-29	Compostos aromaticos e composicoes farmaceuticas que os contem
BR9710366A (pt)	1999-08-17	Derivados de taxane e drogas que os contêm
PT1127052E (pt)	2005-04-29	2-fenilbenzimidazois substituidos sua preparacao e aplicacao
PT1083171E (pt)	2004-09-30	Derivados de pirazolina sua preparacao e aplicacao como medicamentos
PT1189895E (pt)	2005-10-31	Derivados de tiazole e oxazole e sua utilizacao farmaceutica
PT1270565E (pt)	2004-09-30	Furano-2-sulfonamida 4-substituida e sua utilizacao na preparacao de derivados de sulfonilureia
PT879814E (pt)	2002-05-31	Compostos tri-aromaticos composicoes que os contem e utilizacoes
PT1038874E (pt)	2004-06-30	Derivados de oxima e produtos agro-quimicos que os contem
ATE246490T1 (de)	2003-08-15	Pharmazeutische zusammensetzung von topiramate
BR9500784A (pt)	1995-10-24	Composto e formulação farmacêutica
BR9504060A (pt)	1996-09-24	Composto e formulação farmacêutica
PT1202965E (pt)	2005-01-31	Derivados de indol processos para a sua preparacao composicoes farmaceuticas que os contem e a sua aplicacao
PT1112266E (pt)	2003-09-30	4-amino-2-aril-pirimidinas substituidas, sua preparacao, sua utilizacao e composicoes farmaceuticas que as contem.
EE200100022A (et)	2002-06-17	Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon
PT944614E (pt)	2003-01-31	Derivados da benzotiofenocarboxamida e antagonistas de pgd2 que os contem
PT1152765E (pt)	2004-12-31	Etanolato de azitromicina, processo de preparacao e composicoes farmaceuticas que os contem
PT1006110E (pt)	2004-05-31	Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos
BR9607851B1 (pt)	2009-01-13	combinaÇço e formulaÇço farmacÊutica.
PT1119557E (pt)	2004-04-30	Derivados de indeno- nafto- e benzociclohepta-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorecticos
LV12624B (lv)	2001-09-20	Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
PT973763E (pt)	2003-10-31	Novos derivados do 2-(iminometil)amino-fenilo, sua preparacao, sua aplicacao na qualidade de medicamentos e composicoes farmaceuticas que os contem
PT912613E (pt)	2003-01-31	Polissacaridos sinteticos processo para a sua preparacao e composicoes farmaceuticas que os contem
BR9701948A (pt)	1999-01-12	Compostos de pirazol processos para sua produção e hebricidas contendo os mesmos